I second that thought.  Those of us who have been with CTIX for the last 1-2 years are definately desensitized to the magnitude of the "guardian angel" announcement.  Cancer researchers have been working on this for over a decade and we have been given the hints that Kevetrin lab data is showing that it may be working!!  The players in this game know the stakes and are way to sharp to make any missteps announcing success prior to rock solid data to prove it.  We investors need to keep focused on that and continue the waiting game while things work toward their inevitable conclusion.  I only hope we will be so lucky as to get some more P21 hints prior to the end of the year.